HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohamed Naceur Slimane Selected Research

Therapeutic Uses

1/2017Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohamed Naceur Slimane Research Topics

Disease

4Ischemic Stroke
01/2017 - 06/2013
4Coronary Artery Disease (Coronary Atherosclerosis)
02/2015 - 07/2007
4Atherosclerosis
02/2015 - 05/2008
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
03/2013 - 05/2010
3Type 2 Diabetes Mellitus (MODY)
11/2016 - 07/2014
2Inflammation (Inflammations)
11/2016 - 12/2014
2Cardiovascular Diseases (Cardiovascular Disease)
11/2016 - 07/2014
2Rupture
07/2014 - 05/2008
2Atherosclerotic Plaque (Atheroma)
05/2008 - 01/2006
1Acute-Phase Reaction
01/2017
1Brain Injuries (Brain Injury)
01/2017
1Edema (Dropsy)
01/2017
1Herpes Zoster
01/2017
1Infarction (Infarctions)
01/2017
1Ischemia
01/2017
1Obesity
12/2014
1Myocardial Infarction
07/2014
1Xanthomatosis (Xanthoma)
05/2010
1Hypobetalipoproteinemias (Hypobetalipoproteinemia)
03/2009
1Abetalipoproteinemia (Bassen Kornzweig Syndrome)
03/2009
1Aneurysm (Aneurysms)
01/2006
1Microaneurysm
01/2006

Drug/Important Bio-Agent (IBA)

4Apolipoproteins B (ApoB)IBA
12/2012 - 03/2009
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2017 - 06/2013
3Matrix Metalloproteinases (MMPs)IBA
07/2014 - 07/2007
3CholesterolIBA
06/2013 - 03/2009
3LDL Receptors (LDL Receptor)IBA
12/2012 - 05/2010
3ApolipoproteinsIBA
05/2010 - 01/2006
2oxidized low density lipoproteinIBA
02/2015 - 03/2013
2Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
07/2014 - 01/2011
2Lipoproteins (Lipoprotein)IBA
06/2013 - 03/2009
2Triglycerides (Triacylglycerol)IBA
06/2013 - 03/2009
2LDL Lipoproteins (beta Lipoproteins)IBA
03/2013 - 05/2012
2Proprotein Convertase 9IBA
12/2012 - 05/2010
2Apolipoprotein B-100 (Apo B 100)IBA
12/2012 - 05/2012
2Metalloproteases (Metalloproteinases)IBA
05/2008 - 07/2007
2Tissue Inhibitor of Metalloproteinase-1IBA
07/2007 - 01/2006
1OccludinIBA
01/2017
1(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
01/2017
1SolutionsIBA
01/2017
1Therapeutic UsesIBA
01/2017
1Claudin-5IBA
01/2017
1C-Reactive ProteinIBA
11/2016
1Fibrinogen (Factor I)FDA Link
11/2016
1Glucose (Dextrose)FDA LinkGeneric
11/2016
1Glutathione PeroxidaseIBA
11/2016
1Superoxide DismutaseIBA
11/2016
1LDL CholesterolIBA
02/2015
1LipidsIBA
12/2014
1LigandsIBA
12/2014
1Transcription Factors (Transcription Factor)IBA
12/2014
1HDL LipoproteinsIBA
06/2013
1PPAR deltaIBA
06/2013
1SubtilisinIBA
05/2012
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
05/2012
1Apolipoproteins E (ApoE)IBA
01/2006
1Tissue Inhibitor of MetalloproteinasesIBA
01/2006
1ElastinIBA
01/2006